INCY
INCYTE CORP
Latest Form 4:Sale$1.4MbyCAGNONI PABLO J (President, Global Head of R&D) · filed Aug 20, 2026
INCYTE CORP (INCY) has 87 SEC Form 4 filings (159 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Aug 27, 2026.
The most active filer is President, Global Head of R&D CAGNONI PABLO J with 7 filings. Insiders have net sold $20.8M over the trailing 6 months.
- Industry:Biotechnology
- CEO:William J. Meury
- Employees:2,844
- HQ:Wilmington, DE, US
- IPO:1993-11-04
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$55.6M
reported sales (SEC code S)
Unique Insiders
10
in the rolling window
Market Cap
$24.8B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| President, Global Head of R&D | Sale | 10,801 | $1.4M | Aug 20 | SEC ↗ | |
| President, Global Head of R&D | Sale | 10,803 | $1.3M | Aug 14 | SEC ↗ | |
| EVP & Chief Scientific Officer | Sale | 2,207 | $274K | Aug 7 | SEC ↗ | |
| President, Global Head of R&D | Sale | 10,640 | $1.3M | Aug 7 | SEC ↗ | |
Mayes Patrick AFirst in 8 months | EVP & Chief Scientific Officer | Sale | 41,899 | $5.0M | Aug 4 | SEC ↗ |
Mayes Patrick AFirst in 8 months | EVP & Chief Scientific Officer | Sale | 6,055 | $729K | Aug 4 | SEC ↗ |
CAGNONI PABLO JFirst in 4 months | President, Global Head of R&D | Sale | 15,888 | $1.9M | Aug 4 | SEC ↗ |
Issa Mohamed KhairieFirst in 6 months | EVP, Head of U.S. Commercial | Sale | 1,093 | $126K | Jul 20 | SEC ↗ |
| CMO & Head of Late-Stage Dev. | Sale | 1,877 | $215K | Jul 20 | SEC ↗ | |
Stein Steven HFirst in 6 months | CMO & Head of Late-Stage Dev. | Sale | 28,237 | $3.2M | Jul 16 | SEC ↗ |
| Principal Accounting Officer | Sale | 2,639 | $264K | Jun 8 | SEC ↗ | |
Tray ThomasFirst in 5 months | Principal Accounting Officer | Sale | 2,051 | $200K | May 28 | SEC ↗ |
Clancy Paul JFirst filing | Director | Sale | 15,000 | $1.4M | May 21 | SEC ↗ |
| President, Global Head of R&D | Sale | 18,667 | $1.8M | Apr 21 | SEC ↗ | |
| President, R&D | Sale | 18,667 | $1.8M | Mar 19 | SEC ↗ | |
CAGNONI PABLO JFirst filing | President, R&D | Sale | 18,668 | $1.9M | Feb 23 | SEC ↗ |
Issa Mohamed KhairieFirst filing | EVP, Head of US Oncology | Sale | 10,856 | $1.2M | Jan 8 | SEC ↗ |
| EVP & Chief Medical Officer | Sale | 15,634 | $1.6M | Jan 7 | SEC ↗ | |
| Principal Accounting Officer | Sale | 600 | $59K | Dec 22 | SEC ↗ | |
| Principal Accounting Officer | Sale | 2,774 | $277K | Dec 22 | SEC ↗ | |
Morrissey Michael JamesFirst filing | EVP, Head of Tech. Operations | Sale | 54,008 | $5.3M | Dec 18 | SEC ↗ |
Morrissey Michael JamesFirst filing | EVP, Head of Tech. Operations | Sale | 4,323 | $420K | Dec 18 | SEC ↗ |
Mayes Patrick AFirst filing | EVP & Chief Scientific Officer | Sale | 5,553 | $531K | Dec 12 | SEC ↗ |
Mayes Patrick AFirst filing | EVP & Chief Scientific Officer | Sale | 255 | $24K | Dec 12 | SEC ↗ |
| EVP & Chief Medical Officer | Sale | 2,559 | $263K | Dec 3 | SEC ↗ | |
| EVP & Chief Medical Officer | Sale | 20,105 | $2.1M | Dec 3 | SEC ↗ | |
Tray ThomasFirst filing | Principal Accounting Officer | Sale | 169 | $17K | Nov 25 | SEC ↗ |
Tray ThomasFirst filing | Principal Accounting Officer | Sale | 600 | $62K | Nov 25 | SEC ↗ |
| EVP & General Counsel | Sale | 278 | $29K | Nov 19 | SEC ↗ | |
Hoppenot HerveFirst filing | Director | Sale | 187,500 | $19.8M | Nov 12 | SEC ↗ |
Stein Steven HFirst filing | EVP & Chief Medical Officer | Sale | 5,233 | $535K | Nov 7 | SEC ↗ |
| EVP & General Counsel | Sale | 598 | $61K | Nov 6 | SEC ↗ | |
Heeson LeeFirst filing | EVP, Head of Incyte Intl | Sale | 3,074 | $289K | Nov 5 | SEC ↗ |
| EVP & General Counsel | Sale | 277 | $24K | Oct 17 | SEC ↗ | |
| EVP & General Counsel | Sale | 599 | $53K | Oct 6 | SEC ↗ | |
| EVP & General Counsel | Sale | 3,501 | $299K | Oct 6 | SEC ↗ | |
| EVP & General Counsel | Sale | 278 | $23K | Sep 18 | SEC ↗ | |
Denton Sheila A.First filing | EVP & General Counsel | Sale | 598 | $51K | Sep 4 | SEC ↗ |
Related companies
INCYTE CORP is in the Services sector.